KEMPHARM, INC.
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 73.13B | ||||||
| 10.38B | ||||||
| 5.16B | ||||||
| 4.73B | ||||||
| 3.81B | - | - |
